EUVIMEDEUVIMED entdecken
Crossref

Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis

Guanzhong He, Yongchun Pan, Fei Zeng, Shurong Qin, Xiaowei Luan, Qianglan Lu, Chen Xie, Pengfei Hu iD, Yanfeng Gao, Jingjing Yang, Bangshun He, Yujun Song iD

ACS Nano · 26.03.2024 · 18 (12) · 9031-9042

DOI: 10.1021/acsnano.3c12796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 12.03.2024. Verfasst von Guanzhong He und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Jiangsu Key Laboratory of Artificial Func…. Hauptthemen laut MEDLINE: Copper, Nanoparticles. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, National Key Research and Development Program of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperNanoparticlesMicrofluidicsApoptosisHyaluronic AcidHydrogen

Stichwörter der Autor:innen

apoptosiscopper hydridecuproptosishydrogen therapymicrofluidics

Substanzen

CopperHyaluronic AcidHydrogen

Autor:innen und Institutionen

  • College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing 210023, China.
  • Laboratory for Microstructures, School of Materials Science and Engineering, Shanghai University, Shanghai 200444, China.
  • School of Medical Imaging, Wannan Medical College, Wuhu 241002, China.
  • Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.

ORCID-Profile: Pengfei Hu, Yujun Song

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • National Key Research and Development Program of China
  • Natural Science Foundation of Jiangsu Province
  • High Level Innovation and Entrepreneurial Research Team Program in Jiangsu
  • National Natural Science Foundation of China
  • State Key Laboratory of Analytical Chemistry for Life Science

Zitieren

APA

He, G., Pan, Y., Zeng, F., Qin, S., Luan, X., Lu, Q., Xie, C., Hu, P., Gao, Y., Yang, J., He, B., & Song, Y. (2024). Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis. ACS Nano, 18(12), 9031-9042. https://doi.org/10.1021/acsnano.3c12796

Vancouver

He G, Pan Y, Zeng F, Qin S, Luan X, Lu Q, et al. Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis. ACS Nano. 2024;18(12):9031-9042. doi:10.1021/acsnano.3c12796

BibTeX
@article{He2024,
  author = {He, Guanzhong and Pan, Yongchun and Zeng, Fei and Qin, Shurong and Luan, Xiaowei and Lu, Qianglan and Xie, Chen and Hu, Pengfei and Gao, Yanfeng and Yang, Jingjing and He, Bangshun and Song, Yujun},
  title = {Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {12},
  pages = {9031--9042},
  doi = {10.1021/acsnano.3c12796}
}
Kostenlos starten →